Integrated multi‐omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancerJialin Meng, Chang Yin Liang, Fangrong Yan et al.|Clinical and Translational Medicine|2021Cited by 34
1469MO Liver resection versus continued atezolizumab plus bevacizumab (atezo/bev) in locally advanced hepatocellular carcinoma (HCC) after atezo/bev treatment (TALENTop): A multicenter, open-label, randomized phase III trialHui‐Chuan Sun, Xiao‐Dong Zhu, Jun Fan et al.|Annals of Oncology|2025Cited by 3